MarketCap
Facebook
X
TelegramQuarterly report 2023-Q3
added 11-07-2023
Eargo DSO Ratio 2011-2025 | EAR
Annual DSO Ratio Eargo
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 70.8 | 92.8 | 10 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 92.8 | 10 | 57.9 |
Quarterly DSO Ratio Eargo
| 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10.9 | 16.2 | 14.8 | - | 77.3 | 154 | 123 | - | - | 41.3 | 18.9 | - | 19 | 21.7 | 21.1 | - | 12.1 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 154 | 10.9 | 44.2 |
DSO Ratio of other stocks in the Medical devices industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
GenMark Diagnostics, Inc.
GNMK
|
44.2 | - | - | $ 1.77 B |  USA |
 |
Abiomed
ABMD
|
39.2 | - | - | $ 17.2 B | USA |
 |
Acutus Medical
AFIB
|
746 | - | -26.83 % | $ 2.62 M | USA |
 |
Lianluo Smart Limited
LLIT
|
215 | - | 24.59 % | $ 44.8 M |  China |
 |
Apyx Medical Corporation
APYX
|
85.8 | $ 3.82 | -1.04 % | $ 132 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
724 | - | -5.86 % | $ 30.6 M | USA |
 |
Bio-Rad Laboratories
BIO
|
66.9 | $ 303.24 | -1.58 % | $ 8.56 B | USA |
 |
Apollo Endosurgery
APEN
|
59.5 | - | - | $ 475 M | USA |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
InMode Ltd.
INMD
|
5.36 | $ 14.41 | -0.69 % | $ 1.14 B |  Israel |
 |
Bruker Corporation
BRKR
|
57.3 | $ 44.89 | -0.54 % | $ 6.69 K | USA |
 |
Allied Healthcare Products
AHPI
|
161 | - | 3.58 % | $ 2.21 M | USA |
 |
Abbott Laboratories
ABT
|
58.7 | $ 127.97 | 1.99 % | $ 223 B | USA |
 |
Boston Scientific Corporation
BSX
|
65.7 | $ 92.24 | -0.36 % | $ 136 B | USA |
 |
Conformis
CFMS
|
55.4 | - | - | $ 16.4 M | USA |
 |
CryoLife, Inc.
CRY
|
70.3 | - | -4.14 % | $ 702 M | USA |
 |
EDAP TMS S.A.
EDAP
|
91.8 | $ 2.85 | -1.15 % | $ 106 M |  France |
 |
Cardiovascular Systems
CSII
|
61.6 | - | 0.15 % | $ 844 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
52.9 | - | 1.15 % | $ 34.5 M | USA |
 |
Cutera
CUTR
|
327 | - | -10.19 % | $ 1.99 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
62.7 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
85.4 | - | 0.03 % | $ 1.58 B | Israel |
 |
Misonix, Inc.
MSON
|
64.6 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
120 | - | - | $ 111 M |  Canada |
 |
Dynatronics Corporation
DYNT
|
41.6 | - | 14.99 % | $ 929 K | USA |
 |
Intersect ENT, Inc.
XENT
|
66.1 | - | - | $ 955 M | USA |
 |
Cognyte Software Ltd.
CGNT
|
72 | $ 9.66 | -2.03 % | $ 694 M | Israel |
 |
Second Sight Medical Products
EYES
|
49.1 | - | -0.97 % | $ 54.4 M | USA |
 |
Align Technology
ALGN
|
86.7 | $ 164.67 | -0.46 % | $ 12.3 B | USA |
 |
IRIDEX Corporation
IRIX
|
45.6 | $ 0.94 | 2.17 % | $ 15.2 M | USA |
 |
Accuray Incorporated
ARAY
|
69.7 | $ 1.05 | -0.94 % | $ 108 M | USA |
 |
IRadimed Corporation
IRMD
|
56.8 | $ 96.5 | 0.28 % | $ 1.22 B | USA |
 |
Avinger
AVGR
|
49.4 | - | -20.74 % | $ 369 K | USA |
 |
ClearPoint Neuro
CLPT
|
46.1 | $ 12.46 | -1.97 % | $ 337 M | USA |
 |
FONAR Corporation
FONR
|
237 | $ 14.63 | -0.81 % | $ 95.9 M | USA |
 |
AxoGen
AXGN
|
48 | $ 30.07 | -1.05 % | $ 1.33 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
49.2 | - | - | $ 3.31 B | USA |
 |
GBS
GBS
|
61.2 | - | -0.57 % | $ 7.12 M | USA |
 |
CONMED Corporation
CNMD
|
67 | $ 40.19 | -1.56 % | $ 1.24 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
68.6 | $ 17.8 | 1.14 % | $ 411 M | USA |
 |
Globus Medical
GMED
|
76.9 | $ 86.5 | -0.22 % | $ 11.7 B | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
60.3 | $ 13.47 | 0.34 % | $ 1.04 B | USA |
 |
Aziyo Biologics
AZYO
|
51.9 | - | 1.37 % | $ 20.5 M | USA |
 |
Alphatec Holdings
ATEC
|
46.4 | $ 19.98 | 0.1 % | $ 2.86 B | USA |
 |
Aethlon Medical
AEMD
|
40.7 | $ 3.2 | -6.03 % | $ 4.99 M | USA |
 |
LivaNova PLC
LIVN
|
59.4 | $ 62.63 | -0.19 % | $ 3.4 B |  Britain |
|
LENSAR
LNSR
|
34.4 | $ 11.59 | 0.7 % | $ 133 M | USA |
 |
Establishment Labs Holdings
ESTA
|
123 | $ 72.81 | 0.41 % | $ 2.05 B |  Costa-rica |